Report : Lyophilization Services for Biopharmaceuticals Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Service Type (Product and Cycle Development, Clinical Manufacturing, Commercial Manufacturing, Freeze Drying Analytical Services), End User (Pharmaceutical and Biotechnology Companies, Research Institutes, Other), and Geography
Product and Cycle Development Segment to Drive Growth of Lyophilization Services for Biopharmaceutical Market during 2020-2027
According to our new market research study titled "Lyophilization Service for Biopharmaceuticals Market - Global Analysis and Forecast - by Service Type, and End User" the global lyophilization service for biopharmaceutical market is expected to reach US$ 1,456.74 million by 2027 from US$ 702.06 million in 2019; it is estimated to grow at a CAGR of 9.7% from 2020 to 2027. The report highlights the trends prevalent in the global lyophilization service for biopharmaceuticals market, and the drivers and deterrents pertaining to its growth.
Based on service type, the lyophilization service for biopharmaceuticals market is segmented into product and cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services. In terms of service type, the commercial manufacturing segment held the highest share of the lyophilization services for biopharmaceuticals market in 2019; however, the product and cycle development segment is anticipated to witness a significant growth rate during the forecast period. The growth of the market is attributed to the advantages offered by the lyophilization process such as increased shelf life for both small and large molecule drugs, stabilizing formulation by commercially validated method, and reduces cost for complex logistics such as rigorous cold-chain custody validation regimes and constant documentable refrigeration at the dispensary level.
The growth of the market is attributed to the factors such as rising demand for lyophilized products, and rapid growth in contract manufacturing and lyophilization services across the world. On the other hand, the demerits associated with lyophilization process such as leakage during filling, are the major factors hindering the market growth.
ATTWILL Medical Solutions; Axcellerate Pharma LLC.; AB BioTechnologies, Inc.; Berkshire Sterile Manufacturing, Inc.; Emergent BioSolutions; LSNE Contract Manufacturing; Albany Molecular Research (AMRI); Lyophilization Technology, Inc.; Jubilant HollisterStier LLC; Biofortuna Ltd; and Synerlab Group are some of the prominent players operating in the lyophilization services for biopharmaceuticals market. The market players are focused on organic strategies to sustain their position in the market. For instance, in June 2020, Berkshire Sterile Manufacturing (BSM) has secured US$ 16.5 million financing from Berkshire Bank and Lee Bank to expand its operations in Lee. This financing will be used to add manufacturing capabilities including an additional state-of-the-art robotic line for producing sterile drug products such as vials, syringes, and cartridges.
The report segments the global lyophilization services for biopharmaceuticals market as follows:
By End User